These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30581922)

  • 1. Modeling interregional research collaborations in German biotechnology using industry directory data.
    Mitze T; Strotebeck F
    Data Brief; 2019 Feb; 22():169-180. PubMed ID: 30581922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Business Ethics 101 for the biotech industry.
    MacDonald C
    BioDrugs; 2004; 18(2):71-7. PubMed ID: 15046523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Co-authorship Networks to Map and Analyse Global Neglected Tropical Disease Research with an Affiliation to Germany.
    Bender ME; Edwards S; von Philipsborn P; Steinbeis F; Keil T; Tinnemann P
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004182. PubMed ID: 26719978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial risk of the biotech industry versus the pharmaceutical industry.
    Golec J; Vernon JA
    Appl Health Econ Health Policy; 2009; 7(3):155-65. PubMed ID: 19799470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDH-NET: a South-North-South collaboration to build sustainable research capacities on social determinants of health in low- and middle-income countries.
    Cash-Gibson L; Guerra G; Salgado-de-Snyder VN
    Health Res Policy Syst; 2015 Oct; 13():45. PubMed ID: 26490263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of a collaboration network and its impact on innovation performance under the background of government-funded support: an empirical study in the Chinese wind power sector.
    Jiao J; Xu Y; Li J; Yang R
    Environ Sci Pollut Res Int; 2021 Jan; 28(1):915-935. PubMed ID: 32820450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Network Directory Service: Infrastructure to enable collaborations across distributed research networks.
    Malenfant JM; Hochstadt J; Nolan B; Barrett K; Corriveau D; Dee D; Harris M; Herzig-Marx C; Nair VP; Wyner Z; Brown JS
    Learn Health Syst; 2019 Apr; 3(2):e10187. PubMed ID: 31245605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing university-business collaborations for moderate innovators: Implications for university-led innovation policy evaluation.
    Marra M; Alfano V; Celentano RM
    Eval Program Plann; 2022 Dec; 95():102170. PubMed ID: 36202045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project.
    Edmunds LD; Gluderer S; Ovseiko PV; Kamerling R; Ton J; Vis L; Jenni M; Tutton G; Lawton-Smith H; Nadabán MV; Rab M; Rees J; Anson J; Rushforth AD; Allen M; Buchan AM; Vendrell M; Casta A; Mehes G; Hogendoorn PCW; Hafen E; Hassan AB
    Health Res Policy Syst; 2019 Jan; 17(1):10. PubMed ID: 30691504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care innovation: progress report and focus on biotechnology.
    Read JL; Lee KB
    Health Aff (Millwood); 1994; 13(3):215-25. PubMed ID: 7927152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whither geographic proximity? Bypassing local R&D units in foreign university collaboration.
    Belderbos R; Grabowska M; Kelchtermans S; Leten B; Jacob J; Riccaboni M
    J Int Bus Stud; 2021; 52(7):1302-1330. PubMed ID: 33867593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What affects the innovation performance of small and medium-sized enterprises (SMEs) in the biotechnology industry? An empirical study on Korean biotech SMEs.
    Kang KN; Lee YS
    Biotechnol Lett; 2008 Oct; 30(10):1699-704. PubMed ID: 18506395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption.
    Ii SS; Fitzgerald L; Morys-Carter MM; Davie NL; Barker R
    Health Policy; 2018 Feb; 122(2):175-183. PubMed ID: 29191387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swiss biotech--an overview of the industry and the key stakeholders 2010.
    Alexakis DP
    Chimia (Aarau); 2010; 64(11):777-9. PubMed ID: 21197838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. China Biotech Scene, U.S. Collaborations Grow.
    Cancer Discov; 2020 Mar; 10(3):336. PubMed ID: 32024633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).
    Hu H; Chung CC
    Int J Health Policy Manag; 2015 Sep; 4(12):823-9. PubMed ID: 26673466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.
    Fernald KD; Pennings HP; van den Bosch JF; Commandeur HR; Claassen E
    PLoS One; 2017; 12(2):e0172488. PubMed ID: 28231332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovation in biotechnology: moving from academic research to product development--the case of biosensors.
    Siontorou CG; Batzias FA
    Crit Rev Biotechnol; 2010 Jun; 30(2):79-98. PubMed ID: 20214418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to set up collaborations between academia and industrial biotech companies.
    Pronk JT; Lee SY; Lievense J; Pierce J; Palsson B; Uhlen M; Nielsen J
    Nat Biotechnol; 2015 Mar; 33(3):237-40. PubMed ID: 25748909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.